Skip to content
Screener

Q2 Holdings QTWO Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

HTF
Heartflow, Inc.HTFL
$95.5K+35.9%
TRV
Trevi Therapeutics, Inc.TRVI
$295.25K+5.8%
Albany International Inc. logo
Albany International Inc.AIN
$251K
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$844.25K
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$527.25K-81.4%
AVN
AVNSAVNS
$375K

Other financials

Income statement

See full
Revenue$219.8M+12.6%
Gross profit$130.2M+24.5%
Operating income$29.3M+198%
Net income$29.9M+154%
EPS (diluted)$0.46+156%

Balance sheet

See full
Cash & equivalents$99.9M-73.5%
Total debt$40.9M-92.4%
Total equity$643.5M+10.1%
Total assets$968.4M-30.1%

Cash flow

See full
Operating cash flow$60.7M+24.7%
CapEx$1.7M+30.1%
Free cash flow$59.0M+24.5%

Valuation

See full
Market cap$3.95B-16.3%
Enterprise value$3.89B-20.3%
P/E43×-957×
P/S4.7×-1.7×

Profitability

See full
Gross margin57%+4.4pp
Operating margin10%+9.7pp
Net margin10.9%+10.2pp
FCF margin25.2%+2.0pp

Returns & leverage

See full
Return on equity15%+14.1pp
Debt / equity0.1×-0.9×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Q2 Holdings in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The source filing: Q2 Holdings’s 10-K, filed February 11, 2026.

Filed
Feb 10, 2026, 7:00 PM EST
Fiscal year
FY2025
Accession
0001410384-26-000006
Line itemYear Ended December 31, 2025 / AmountYear Ended December 31, 2025 / PercentageYear Ended December 31, 2024 / AmountYear Ended December 31, 2024 / PercentageYear Ended December 31, 2023 / AmountYear Ended December 31, 2023 / Percentage
Stock compensation2,1163.86%6,840(22.17)%10,070(16.29)%
Other2210.40%38(0.12)%185(0.30)%
Tax credits
Research and development credit(13,409)(24.50)%
Changes in valuation allowance(1,733)(3.17)%2,366(7.67)%5,052(8.17)%
Changes in UTP2,9955.47%376(1.22)%(257)0.42%
Other
Other3490.64%(197)0.64%658(1.07)%

Item 16. Form 10-K Summary.

FAQ

What is Q2 Holdings's effective income tax rate reconciliation, tax credit, research, amount?
Q2 Holdings (QTWO) reported effective income tax rate reconciliation, tax credit, research, amount of $3.35M in Q4 2025.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
The total monetary value of tax credits claimed for qualified research and development activities. This reflects the company's ability to reduce its effective tax rate by leveraging government incentives for innovation.

Ask your AI about Q2 Holdings's effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude